When Does a Patient Need BiPAP?
BiPAP should be initiated when a patient presents with acute respiratory distress characterized by increased work of breathing, hypercapnia with respiratory acidosis (particularly pH <7.35), or hypoxemic respiratory failure that remains inadequately oxygenated despite conventional oxygen therapy, provided the patient is alert, cooperative, and hemodynamically stable. 1, 2
Primary Indications for BiPAP
Acute Hypercapnic Respiratory Failure
- BiPAP is most effective in acute exacerbations of COPD with respiratory acidosis, showing success rates of approximately 80% (20 of 25 patients) in avoiding intubation 3
- Initiate when pH is declining and PCO2 is rising despite standard bronchodilator therapy 1
- BiPAP offsets intrinsic PEEP in COPD, recruits collapsed alveoli, and improves ventilation-perfusion matching 1
Acute Cardiogenic Pulmonary Edema
- BiPAP reduces work of breathing and improves oxygenation in acute heart failure syndrome 4
- However, be cautious as some evidence suggests BiPAP may be associated with higher myocardial infarction rates compared to CPAP in this population 4
- Consider CPAP as first-line for cardiogenic pulmonary edema unless hypercapnia is present 4
Hypoxemic Respiratory Failure
- BiPAP can be used when PaO2/FiO2 ratio is low despite high-flow oxygen 3
- Success rate is lower (approximately 48%, or 15 of 31 patients) compared to hypercapnic failure 3
- The risk of BiPAP failure is 2.6 times greater in hypoxemic versus hypercapnic respiratory failure 3
Post-Extubation Respiratory Failure
- BiPAP is highly effective (80% success rate) when initiated within 48 hours of extubation for patients developing respiratory distress 3
- Prevents reintubation and reduces ICU length of stay 3
Acute Asthma
- BiPAP may offer short-term support for patients with acute respiratory failure from severe asthma 4
- Requires that the patient is alert with adequate spontaneous respiratory effort 4
- Can delay or eliminate the need for endotracheal intubation 4
Clinical Parameters Indicating BiPAP Need
Respiratory Distress Criteria
Look for the following objective findings 2:
- Respiratory rate >30 breaths/minute
- Oxygen saturation <90% on conventional oxygen therapy
- Use of accessory muscles of respiration
- Paradoxical abdominal breathing
- Patient subjectively reporting severe dyspnea
Blood Gas Criteria
- pH <7.35 with elevated PCO2 (primary indication for hypercapnic failure) 1, 3
- PaO2/FiO2 ratio <300 despite oxygen supplementation 3
- Rising PCO2 trend despite treatment 1
Hemodynamic Stability Requirements
Patient must be 2:
- Cooperative and able to protect airway
- Hemodynamically stable (no vasopressor requirement)
- Able to tolerate face mask
- Not requiring immediate intubation
Initial BiPAP Settings
Start with IPAP of 8-10 cm H2O and EPAP of 4-5 cm H2O 2, 5
- Gradually increase IPAP by 2 cm H2O increments to 14-20 cm H2O as tolerated 1, 5
- Increase EPAP by 1 cm H2O increments to 4-8 cm H2O as needed 1, 5
- Typical effective settings: IPAP 14-20 cm H2O, EPAP 4-8 cm H2O 1, 5
Contraindications and When NOT to Use BiPAP
Absolute Contraindications
- Apnea or impending respiratory arrest (intubate immediately) 4
- Coma or severely depressed mental status 4
- Inability to protect airway 4
- Facial trauma or burns preventing mask seal 1
- Hemodynamic instability requiring vasopressors 2
Relative Contraindications
- Recent myocardial infarction (use with extreme caution in acute heart failure) 4, 1
- Severe hypoxemia unresponsive to initial trial 3
- Copious secretions or inability to clear airway 4
- Recent upper airway or gastrointestinal surgery 1
Special Populations Requiring Caution
- Patients with massive hemoptysis should have BiPAP discontinued during active bleeding 4
- Patients with pneumothorax should have BiPAP discontinued until chest tube placement 4
Monitoring Response and Success Criteria
Early Response Indicators (Within 1-2 Hours)
Successful BiPAP therapy shows 2, 3:
- Decreased respiratory rate (mean decrease from 34 to 28 breaths/minute) 2
- Improved oxygen saturation (mean increase from 80% to 91%) 2
- Reduced oxygen requirement (mean decrease from 4.6 to 2.3 L/min) 2
- Increased pH and decreased PCO2 in hypercapnic patients 3
- Increased PaO2/FiO2 ratio in hypoxemic patients 3
Duration of BiPAP Dependency
- Average duration of BiPAP use in successful cases is approximately 35 hours 3
- Perform daily trials of unassisted breathing to assess readiness for discontinuation 3
When BiPAP Fails: Intubation Criteria
Proceed to intubation if 4, 3:
- No improvement or worsening after 1-2 hours of BiPAP trial
- Persistent or worsening hypercapnia with pH <7.25
- Worsening mental status or inability to cooperate
- Hemodynamic deterioration
- Inability to manage secretions
- Patient exhaustion despite BiPAP support
Common Pitfalls to Avoid
Mask Selection and Fit
- Poor mask fit is the most common cause of BiPAP failure 1
- Ensure proper seal without excessive tightening (causes skin breakdown)
- Consider different mask types (full face vs. nasal) based on patient tolerance 1
Pressure Settings
- Excessive pressure settings can cause gastric distension or paradoxically increase work of breathing 1
- Start low and titrate gradually based on patient comfort and objective parameters 2, 5
- Do not exceed IPAP of 20 cm H2O in most adult patients 1
Patient Selection Errors
- Do not delay intubation in patients who clearly need invasive ventilation 4
- BiPAP is a temporizing measure, not a substitute for definitive airway management in unstable patients 4
- Higher APACHE II scores predict BiPAP failure—use clinical judgment 3